Furthermore, we observed that the KRAS signaling pathway, the E2F target and apoptosis by CDKN1A via TP53-signaling were remarkably downregulated in the SoS samples compared to the healthy controls. This evidence concerns the gene CDKN1A and spondylo-ocular syndrome.